COAGUCHEK ® XS SYSTEM
Report
- Report Number
- 1823260-2023-02458
- Event Type
- Malfunction
- Date Received
- July 24, 2023
- Date of Event
- July 5, 2023
- Report Date
- July 24, 2023
- Manufacturer
- ROCHE DIAGNOSTICS
- Product Code
- GJS
- UDI-DI
- 00365702127104
- PMA / PMN Number
- K062925
- Removal / Correction Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- OTHER
Narratives
E3-OCCUPATION IS PATIENT/CONSUMER ON A REGULAR BASIS, COAGUCHEK STRIPS OF LOTS CURRENTLY VALID IN THE MARKET ARE TESTED AS PART OF ROUTINE RETENTION TESTING AND RESULTS HAVE PASSED THE INTERNAL INSPECTION. PRODUCT LABELING STATES: "THE COAGUCHEK SYSTEM USES HUMAN RECOMBINANT THROMBOPLASTIN. THEREFORE, THE COMPARABILITY TO OTHER HUMAN RECOMBINANT THROMBOPLASTINS IS BEST, WHEREAS DEVIATIONS CAN OCCUR WHEN COMPARED TO METHODS USING OTHER THROMBOPLASTINS. HOWEVER, THOSE DEVIATIONS BETWEEN THROMBOPLASTINS OF DIFFERENT ORIGIN (E.G., RABBIT BASED) ARE NOT SPECIFIC TO COAGUCHEK PRODUCTS. SIMILAR DIFFERENCES CAN BE OBSERVED WHEN A HUMAN RECOMBINANT THROMBOPLASTIN BASED LABORATORY METHOD IS COMPARED TO OTHER LABORATORY METHODS." THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM. THE CAUSE OF THE EVENT COULD NOT BE DETERMINED. N.
WE RECEIVED AN ALLEGATION OF DISCREPANT INR RESULTS WITH COAGUCHEK XS METER SERIAL NUMBER (B)(6) COMPARED TO A LABORATORY USING AN UNKNOWN REAGENT. AT 5:15 PM, THE METER RESULT WAS 4.4 INR. THE PATIENT WAS NOT FEELING WELL SO THEY WENT TO THE ER FOR A LAB TEST. AT 6:45 PM TO 7:00 PM, THE RESULT FROM THE LABORATORY WAS 2.65 INR. THE PATIENT'S THERAPEUTIC RANGE IS 2.0-3.0 INR. THE PATIENT'S TESTING FREQUENCY VARIES BETWEEN WEEKLY TO MONTHLY BASED ON IF THEY ARE IN THEIR NORMAL RANGE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 632424 | COAGUCHEK ® XS SYSTEM | PROTHROMBIN TIME TEST STRIPS | GJS | ROCHE DIAGNOSTICS | NA | 65031621 | 00365702127104 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 57 YR | Male | AMOXICILLIN| ATORVASTATIN| BIKTARVY| CARVEDILOL| DOXYCYCLINE| DULOXETINE| OTEZLA| PANTOPRAZOLE| TYLENOL 3| WARFARIN |